WG
AGN

Winchester Group’s Allergan Inc AGN Stock Holding History

Winchester Group’s Portfolio AGN Stock Details AGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2013
Q3 		$2.78M Buy
30,770
+17,295
+128% +$1.55M 0.61% 46
2013
Q2 		$1.14M Buy
+13,475
New +$1.4M 0.24% 100

Other funds holding AGN

Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
State Farm Mutual Automobile Insurance
State Farm Mutual Automobile Insurance Bloomington, Illinois $146B AUM 55.73% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $167B AUM 44.17% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
O
OppenheimerFunds New York $80.4B AUM 15.1% 1-Year Est. Return
Macquarie Group
Macquarie Group Sydney, NSW 2000, Australia $23.2B AUM 40.19% 1-Year Est. Return
Sands Capital Management
Sands Capital Management Arlington, Virginia $26.9B AUM 34.44% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Winchester Group's AGN Position: Q3 2013 in Review

Winchester Group increased its Allergan Inc (AGN) stake by 128% in Q3 2013, buying an estimated $1.55M and bringing the position to 30,770 shares worth $2.78M. The position accounts for 0.61% of the portfolio, ranked #46.

Winchester Group first reported a position in AGN in Q2 2013 and has held it in 2 quarters since. 642 funds tracked by Wall St. Rank hold AGN as of Q3 2013.

  • Winchester Group held 30,770 shares of Allergan Inc worth $2.78M as of Q3 2013.
  • Winchester Group bought 17,295 Allergan Inc shares in Q3 2013, an estimated $1.55M.
  • Allergan Inc made up 0.61% of Winchester Group's portfolio in Q3 2013, its #46 holding.
  • Winchester Group first reported a position in Allergan Inc in Q2 2013 and has held it in 2 quarters since.
  • 642 funds tracked by Wall St. Rank held Allergan Inc as of Q3 2013.

Based on Winchester Group's 13F filing for Q3 2013, filed 16 Oct 2013.